Navigation Links
Hyperviscous fluids: Better treatment for severe blood loss

Intravenous administration of isotonic fluids is the standard emergency treatment in the U.S. for patients with severe blood loss, but UC San Diego bioengineering researchers have reported improved resuscitation with a radically different approach. Building on earlier studies in humans that have shown benefits of intravenous fluids that are eight times saltier than normal saline, the researchers combined hypertonic saline with viscosity enhancers that thicken blood.

Reporting in the journal Resuscitation in an article that is available online, the researchers describe dramatic increases in beneficial blood flows in the small blood vessels of hamsters with the combined hypertonic saline and viscosity enhancement approach. The fluid was given to animals after as much as half of their blood was removed to simulate human blood losses on the battlefield, in traffic accidents and in operating rooms.

The team led by Marcos Intaglietta, a professor of bioengineering at the Jacobs School of Engineering, reported that the new approach sharply improved the animals functional capillary density, a key measure of healthy blood flow through tissues and organs.

Of course, trauma physicians want to get the blood flowing as soon as possible, and increasing the viscosity of blood may not make any sense to them, said Intaglietta. However, our results are highly suggestive that increasing viscosity rather and partially restoring blood volume is a better way to increase blood flow through tissues. These findings also are consistent with recent discoveries showing that higher shear forces of more viscous blood leads to dilation of small blood vessels.

Treating blood loss is a critical medical issue because trauma is the leading cause of death among North Americans 1 to 44 years old. Whether injured on the freeway or wounded in battlefield, loss of 40 percent or more of a patients blood is immediately life-threatening. Physicians and emergency workers must act quickly.

The majority of trauma deaths are due to severe brain injury or a dangerous condition resulting from blood loss called hypovolemic shock. When too little blood flows through the bodys organs, the heart begins beating rapidly, the skin becomes cold and pale, blood pressure plummets, and patients exhibit mental confusion. Hypovolemic shock can progress within a matter of one or two hours to organ failure and death.

The bible of trauma physicians and emergency workers, the Advanced Trauma Life Support (ATLS) guidelines, emphasize that physicians first control bleeding and then provide limited fluid resuscitation, a strategy known as "permissive hypotension" until control of hemorrhage is obtained. The ATLS guidelines, developed by the American College of Surgeons and adopted in more than 30 countries, were modified to lower the volume of isotonic fluids given after several studies demonstrated that sudden increases in blood pressure (without immediate bleeding control) would "pop" clots that the body forms to control bleeding.

Over several decades, studies involving humans and animals have evaluated hypertonic saline (up to 7.5 percent sodium chloride) versus isotonic saline (0.9 percent sodium chloride). Given intravenously, hypertonic solutions act like magnets, drawing fluid from tissues into the bloodstream, thereby increasing blood volume. Such hypertonic saline has not received the approval of the Food and Drug Administration for clinical use in the United States. Therefore, it is not part of ATLS guidelines.

However, several medical research teams, including one led by Dr. Raul Coimbra, professor of surgery and chief, Division of Trauma, Surgical Critical Care and Burns at UC San Diego Medical Center, have investigated the effects of hypertonic saline for almost 20 years. Our level-1 trauma center at UC San Diego is participating in a study of hypertonic saline as part of a multicenter trial sponsored by the National Institutes of Health, said Coimbra. Unfortunately, it will take us two to three more years to finish the trial and determine whether hypertonic saline is superior to conventional isotonic resuscitation.

In Intagliettas study with hamsters in the Jacobs School of Engineerings Department of Bioengineering, 90 minutes after hypertonic saline was given to blood-depleted hamsters about 30 percent of normal flow was reconstituted through skin arterioles, tiny branches of arteries that lead to the even smaller capillaries. The bioengineering researchers quantified blood flow with special microscopic procedures.

In blood-depleted hamsters given both hypertonic saline and a small volume of a commercially available viscosity enhancer called Hextend, blood flow through arterioles improved to 40 percent of normal. When the hypertonic saline, Hextend, and a small volume of another viscosity enhancer called alginate were given, arteriole blood flow improved to 55 percent of normal. Hextend and alginate are plasma volume expanders, substances transfused to maintain the fluid volume of blood.

Our findings suggest that elevating the viscosity of blood after severe blood loss is beneficial in resuscitation, said Intaglietta. In fact, our studies indicate that Hextend and similar plasma extenders could produce even greater benefit if they were formulated with higher viscosities.

Arterioles regulate blood flow by constricting and dilating. A variety of factors in the body influence the process, including the viscosity of plasma, the fluid portion of blood. For example, higher viscosity plasma causes arterioles to dilate.

For centuries, dating back to the time of the early Greeks, the idea has always been that blood is thick, so the sick should be treated by bleeding in order to thin the blood, said Intaglietta. Even as late as World War II and the Vietnam Way, it was thought that adding isotonic fluids to replace blood lost on the battlefield would be good because it lowered blood viscosity, making it easier for the heart to pump.

Intaglietta said that while more research is needed, Our findings and others suggest that the ATLS guidelines need to be modified.

Studies such as Intagliettas are important because it uses not only hypertonic saline, said Coimbra, but also other adjuncts which may increase the effects of hypertonic saline in treating those patients and in advancing our knowledge about shock resuscitation.


Contact: Rex Graham
University of California - San Diego

Related biology news :

1. Standard chemo works better against metastatic BRCA1/2 breast cancer than against sporadic tumors
2. How and where fat is stored predicts disease risk better than weight
3. Continuous oral contraceptives better at easing pain, bleeding
4. David H. Ledbetter, PhD, FACMG is the 2008-2009 Luminex/ACMGF Award recipient
5. Ant guts could pave the way for better drugs
6. Newly defined signaling pathway could mean better biofuel sources
7. Analysis calls for medical device information to better serve patients and doctors
8. Better protection for biomedial devices could result from Rutgers-Camden research
9. Researchers develop better membranes for water treatment, drug delivery
10. Marine scientists warn human safety, prosperity depend on better ocean observing system
11. Human safety, prosperity depend on better ocean observing system: Scientists
Post Your Comments:
Related Image:
Hyperviscous fluids: Better treatment for severe blood loss
(Date:9/30/2015)... 30, 2015  The global glucose monitoring device and diabetes ... says a new report on the industry from Kalorama Information. Sales ... the market, followed by continuous glucose monitoring and sensor segment, ... market for these products in its latest report, The ... , ...
(Date:9/28/2015)... NEW YORK , Sept. 28, 2015 ... platform, announced today that its expedited traveler ...  CLEAR,s innovative platform transforms travel, bringing a ... for its members. "CLEAR offers ... which enhances customer service," said Jim ...
(Date:9/28/2015)... , September 28, 2015 ... Component (Hardware & Software), Product (Scanner & Others), Application ... & Defense, & Others) & Geography Global - Forecast ... expected to reach USD 3627.90 Million by 2020, at ... Browse 65 market data T ables ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... -- Amgen (NASDAQ: AMGN ) and LabCentral announced today ... 2015 selection for Golden Ticket winners, which supply each ... innovative, shared laboratory space designed as a launchpad for ... Mass. Novopyxis and Cocoon Biotech are each ... --> Cambridge, Mass. Novopyxis ...
(Date:10/13/2015)... 2015 Research and Markets( ) has ... Markets for Bone Morphogenetic Protein Growth Factor Therapy - ... --> --> Bone morphogenetic ... of bone after a fracture. In nature, these proteins ... formation of the skeleton. There are twenty different BMPs ...
(Date:10/13/2015)... and SAN DIEGO , ... Mast Therapeutics, Inc. have agreed to collaborate in the ... poloxamer 188 NF, marketed by BASF under the Kolliphor ... a variety of pharmaceutical and biological applications, such as ... is the starting material for Mast,s lead product candidate. ...
(Date:10/13/2015)... ... October 13, 2015 , ... Exotic Automation & ... solutions and components, is opening its latest Parker Store retail location in Ann, ... Exotic’s second major expansion in Metropolitan Detroit in less than a year. The ...
Breaking Biology Technology: